Ostoegenesis imperfecta (OI) or "britt
le bone" disease isassociated with mutations in thegenes for type I co
llagen chains and produces variab
le phenotypes,ranging from
letha
l cases at birth tomi
ld cases with increased bone fractures. The most common OImutations are sing
le base substitutions
leading to rep
lacement of G
ly by another residue, breaking the typica
l(G
ly-X-Y)
n repeating sequencepattern of the co
llagen trip
le-he
lix. Trip
le-he
lica
l peptides weredesigned to focus on residues 892-921of the
lpha.gif" BORDER=0>1 chain of type I co
llagen, where two OI G
ly
Ser mutationsare found in c
lose proximity, a mi
ldmutation at site 901 and a
letha
l mutation at site 913. Peptideswere designed to inc
lude amino acidsequences around these mutation sites, and were synthesized with thenorma
l sequence or with the G
ly
Sermutated sequence. The peptide inc
luding the norma
l sequenceresidues 892-909 with four G
ly-Pro-Hyptrip
lets at the C-terminus formed a stab
le trip
le-he
lix, andintroduction of a Ser residue for G
ly at the 901mutation site
led to a 50%
loss of trip
le-he
lix content and a decreasein therma
l stabi
lity, with
litt
le effecton fo
lding. A peptide inc
luding residues 904-921 again formed astab
le trip
le-he
lix, but the introductionof the G
ly
Ser substitution at site 913
led to a much greaterdecrease in therma
l stabi
lity. These studiesdemonstrate the impact of
loca
l sequences f
lanking the G
ly substitutionon structura
l consequences andsupport the concept of variabi
lity and regiona
l effects a
long theco
llagen mo
lecu
le.